A detailed history of Acuta Capital Partners, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 1,849,402 shares of AADI stock, worth $3.01 Million. This represents 3.54% of its overall portfolio holdings.

Number of Shares
1,849,402
Previous 1,849,402 -0.0%
Holding current value
$3.01 Million
Previous $3.74 Million 15.85%
% of portfolio
3.54%
Previous 2.91%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$12.03 - $14.22 $3.85 Million - $4.55 Million
320,000 Added 20.92%
1,849,402 $26.1 Million
Q3 2021

Nov 15, 2021

BUY
$25.52 - $41.85 $39 Million - $64 Million
1,529,402 New
1,529,402 $44.9 Million

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $34.3M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.